J. Garland

Mr. J.
S.
Garland is a Chairman at LB Pharmaceuticals, Inc., an Independent Director at Olema Pharmaceuticals, Inc. and a Chairman at ALX Oncology Holdings, Inc. He is on the Board of Directors at Enliven Therapeutics, Inc. and Olema Pharmaceuticals, Inc. Mr. Garland was previously employed as a Venture Partner by VV Manager LLC, an Independent Director by Day One Biopharmaceuticals, Inc., a Chief Executive Officer & Director by PACT Pharma, Inc., an Independent Director by Calithera Biosciences, Inc., a President, Chief Executive Officer & Director by Portola Pharmaceuticals LLC, an Independent Director by Karyopharm Therapeutics, Inc., a President by Relypsa, Inc., a Chief Commercial Officer & Executive VP by Exelixis, Inc., a Vice President-Avastin Franchise by Genentech, Inc., and a Head-Sales & Marketing Division by Amgen, Inc. He received his undergraduate degree from California Polytechnic State University (San Luis Obispo) and an MBA from The Fuqua School of Business.